当前位置:首页 - 行情中心 - 回盛生物(300871) - 财务分析

回盛生物

(300871)

  

流通市值:17.19亿  总市值:17.19亿
流通股本:1.66亿   总股本:1.66亿

回盛生物(300871)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润-0.48亿元,每股收益-0.29元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益142341.45万元,未分配利润24973.13万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产291253.33万元,负债148911.89万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入792,553,431.27436,303,723.6206,809,092.091,019,758,798.36
营业总成本838,141,263.93468,045,931.31219,314,493.261,016,321,252.34
营业利润-61,134,868.34-64,634,130.29-21,487,193.8115,082,985.94
利润总额-61,203,620.59-64,686,101.19-21,546,000.0612,441,545.62
净利润-47,615,990.17-51,879,057.19-16,405,616.816,780,818.77
其他综合收益-767,307.88-1,587,603.84--
综合收益总额-48,383,298.05-53,466,661.03-16,405,616.816,780,818.77
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计1,209,306,834.791,235,017,572.571,277,604,103.831,265,980,935.65
非流动资产合计1,703,226,484.151,706,052,986.591,716,234,324.931,709,479,526.47
资产总计2,912,533,318.942,941,070,559.162,993,838,428.762,975,460,462.12
流动负债合计893,126,072.47781,533,939.4797,276,064.2781,076,484.78
非流动负债合计595,992,781.03729,500,296.76686,780,177.54685,102,915.22
负债合计1,489,118,853.51,511,034,236.161,484,056,241.741,466,179,400
归属于母公司股东权益合计1,422,687,148.581,429,736,698.961,509,782,187.021,509,281,062.12
股东权益合计1,423,414,465.441,430,036,3231,509,782,187.021,509,281,062.12
负债和股东权益合计2,912,533,318.942,941,070,559.162,993,838,428.762,975,460,462.12
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计727,679,278.47450,971,927.45224,327,944.231,081,594,132.55
经营活动现金流出小计720,568,634.84481,981,027.82270,607,437.88988,674,786.55
经营活动产生的现金流量净额7,110,643.63-31,009,100.37-46,279,493.6592,919,346
投资活动现金流入小计533,096,404.27325,880,251.36183,452,284.71,069,533,807.36
投资活动现金流出小计659,840,673.74387,391,688.3259,784,477.071,169,837,876.12
投资活动产生的现金流量净额-126,744,269.47-61,511,436.94-76,332,192.37-100,304,068.76
筹资活动现金流入小计423,425,243344,046,379202,776,473264,767,475.65
筹资活动现金流出小计393,775,661206,283,860.72107,572,170.13306,243,839.45
筹资活动产生的现金流量净额29,649,582137,762,518.2895,204,302.87-41,476,363.8
汇率变动对现金及现金等价物的影响-178,476.97-313,967.68-355,524.4-232,826.75
现金及现金等价物净增加额-90,162,520.8144,928,013.29-27,762,907.55-49,093,913.31
期末现金及现金等价物余额139,349,768.58274,440,302.68201,749,381.84229,512,289.39
TOP↑